July 23, 2017 8:06 AM ET


Company Overview of Protea Biosciences Group, Inc

Company Overview

Protea Biosciences Group, Inc., a molecular information company, develops and commercializes life science technologies, products, and services to identify the molecules that are produced by living cells and various life forms. It develops Histology Guided Mass Spec Imaging, a software suite that allows researchers to share, annotate, and direct the analysis of specific tissue morphologies and cell subpopulations by mass spec imaging; and prototype instrumentation of LAESI technology that integrates with laboratory instruments. The company also develops technology to improve the molecular characterization of biotherapeutics; and bioanalytical reagents and products to facilitate sample prepara...

1311 Pineview Drive

Suite 501

Morgantown, WV 26505

United States

Founded in 2001

25 Employees





Key Executives for Protea Biosciences Group, Inc

Chairman and Chief Executive Officer
Age: 71
Total Annual Compensation: $240.0K
President and Chief Business Officer
Age: 50
Total Annual Compensation: $240.0K
Chief Scientific Officer and Vice President of Research & Development
Age: 42
Total Annual Compensation: $180.0K
Age: 48
Compensation as of Fiscal Year 2016.

Protea Biosciences Group, Inc Key Developments

Maged Shenouda Resigns as Director of Protea Biosciences Group, Inc

On June 9, 2017, Maged Shenouda resigned as a Director of Protea Biosciences Group Inc.

Protea Biosciences Group, Inc announced delayed 10-Q filing

On 05/15/2017, Protea Biosciences Group, Inc announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

Protea and Proteos Announce Co-Marketing Agreement

Protea Biosciences Group, Inc. and Proteos, Inc. announced that they have entered into a joint co-marketing agreement. This mutual partnership allows Protea to combine Proteos' protein production capabilities alongside Protea's proprietary bioanalytical services, and allows Proteos to market and promote Protea's proprietary bioanalytical services with their custom protein production services. Recent advancements in recombinant protein production technologies, combined with an ever-increasing understanding of biology, are discovering novel proteins at a rapid pace. These novel proteins are useful in a wide variety of biotherapeutic, industrial and diagnostic applications. With these advances comes the need for seamlessly integrating quantitative analysis of these proteins. The combined availability of the Protea and Proteos technology platforms will benefit companies and research institutions by streamlining their project development cycles. Both companies plan to actively co-market their respective capabilities to the biopharmaceutical, biotechnology, life science and academic sectors.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

Private Placement
October 31, 2016
Private Placement
September 8, 2016

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Protea Biosciences Group, Inc, please visit www.proteabio.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.